Latest Financials News

Peel Mining has secured $21.25 million through a placement and share purchase plan, while appointing a new leadership team to drive a strategic pivot focused on unlocking value from its copper and polymetallic assets in the Cobar Basin.

Sunshine Metals Limited reported a solid cash position of AUD 5.1 million at the end of Q3 2025, supported by a strong financing inflow that offsets ongoing exploration expenditures.

DUG Technology reports a robust start to FY26 with 19% revenue growth and a landmark SaaS and HPCaaS contract, marking key international milestones.

CSL Limited has revised its financial outlook for FY26, citing lower US influenza vaccination rates and government cost controls in China, while postponing the planned demerger of its Seqirus vaccine business and announcing a major cost-saving program.

Global Health Limited has accelerated its MasterCare+ SaaS platform rollout, integrating AI to streamline operations and reduce staff by 10%, while reporting a 25% EBIT improvement despite a delayed R&D refund impacting cash flow.

Sunshine Metals reports significant progress in North Queensland with standout gold intersections at Sybil and a $5 million placement led by Lion Selection. Board reshuffle aligns leadership with growth strategy.

OD6 Metals has selected a cutting-edge rare earth processing flowsheet delivering ~75% recovery of key elements and completed metallurgical drilling at Splinter Rock, supported by a $2.5 million capital raise. The company also commenced Phase 2 drilling at its Gulf Creek Copper Project, maintaining a strong cash position.

Algorae Pharmaceuticals has broadened its commercial footprint in Australia and New Zealand through key licensing agreements, while advancing its AI-driven drug discovery platform and strengthening leadership.

Tarrina Resources is set to acquire promising exploration assets in NSW and SA, backed by a $5 million capital raise. The move aims to reposition the company within the mining sector and secure its ASX listing.

CONNEQT Health has landed a significant Phase 2b clinical trial contract in the US, advancing its footprint in cardiovascular disease research with proprietary vascular assessment technology.

Starpharma has secured two major partnership agreements with Genentech and Radiopharm Theranostics, unlocking significant upfront payments and milestone potential while advancing its clinical pipeline.

Tesoro Gold Limited reported a challenging quarter with significant cash outflows but secured $26.7 million in capital to advance its El Zorro Project. The company aims to sustain operations through a planned second tranche of funding.